Observational study of adult respiratory infections in primary care clinics in Myanmar: understanding the burden of melioidosis, tuberculosis and other infections not covered by empirical treatment regimes.


Journal

Transactions of the Royal Society of Tropical Medicine and Hygiene
ISSN: 1878-3503
Titre abrégé: Trans R Soc Trop Med Hyg
Pays: England
ID NLM: 7506129

Informations de publication

Date de publication:
02 08 2021
Historique:
accepted: 09 02 2021
received: 23 05 2020
revised: 22 01 2021
pubmed: 9 3 2021
medline: 6 8 2021
entrez: 8 3 2021
Statut: ppublish

Résumé

Lower respiratory infections constitute a major disease burden worldwide. Treatment is usually empiric and targeted towards typical bacterial pathogens. Understanding the prevalence of pathogens not covered by empirical treatment is important to improve diagnostic and treatment algorithms. A prospective observational study in peri-urban communities of Yangon, Myanmar was conducted between July 2018 and April 2019. Sputum specimens of 299 adults presenting with fever and productive cough were tested for Mycobacterium tuberculosis (microscopy and GeneXpert MTB/RIF [Mycobacterium tuberculosis/resistance to rifampicin]) and Burkholderia pseudomallei (Active Melioidosis Detect Lateral Flow Assay and culture). Nasopharyngeal swabs underwent respiratory virus (influenza A, B, respiratory syncytial virus) polymerase chain reaction testing. Among 299 patients, 32% (95% confidence interval [CI] 26 to 37) were diagnosed with tuberculosis (TB), including 9 rifampicin-resistant cases. TB patients presented with a longer duration of fever (median 14 d) and productive cough (median 30 d) than non-TB patients (median fever duration 6 d, cough 7 d). One case of melioidosis pneumonia was detected by rapid test and confirmed by culture. Respiratory viruses were detected in 16% (95% CI 12 to 21) of patients. TB was very common in this population, suggesting that microscopy and GeneXpert MTB/RIF on all sputum samples should be routinely included in diagnostic algorithms for fever and cough. Melioidosis was uncommon in this population.

Sections du résumé

BACKGROUND
Lower respiratory infections constitute a major disease burden worldwide. Treatment is usually empiric and targeted towards typical bacterial pathogens. Understanding the prevalence of pathogens not covered by empirical treatment is important to improve diagnostic and treatment algorithms.
METHODS
A prospective observational study in peri-urban communities of Yangon, Myanmar was conducted between July 2018 and April 2019. Sputum specimens of 299 adults presenting with fever and productive cough were tested for Mycobacterium tuberculosis (microscopy and GeneXpert MTB/RIF [Mycobacterium tuberculosis/resistance to rifampicin]) and Burkholderia pseudomallei (Active Melioidosis Detect Lateral Flow Assay and culture). Nasopharyngeal swabs underwent respiratory virus (influenza A, B, respiratory syncytial virus) polymerase chain reaction testing.
RESULTS
Among 299 patients, 32% (95% confidence interval [CI] 26 to 37) were diagnosed with tuberculosis (TB), including 9 rifampicin-resistant cases. TB patients presented with a longer duration of fever (median 14 d) and productive cough (median 30 d) than non-TB patients (median fever duration 6 d, cough 7 d). One case of melioidosis pneumonia was detected by rapid test and confirmed by culture. Respiratory viruses were detected in 16% (95% CI 12 to 21) of patients.
CONCLUSIONS
TB was very common in this population, suggesting that microscopy and GeneXpert MTB/RIF on all sputum samples should be routinely included in diagnostic algorithms for fever and cough. Melioidosis was uncommon in this population.

Identifiants

pubmed: 33681986
pii: 6157741
doi: 10.1093/trstmh/trab024
pmc: PMC8326957
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

914-921

Subventions

Organisme : Wellcome Trust
ID : 106698/Z/14/Z
Pays : United Kingdom
Organisme : Planet Wheeler fund
Organisme : Medical Action Myanmar
Organisme : Royal Society of Tropical Medicine and Hygiene
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Références

PLoS Negl Trop Dis. 2010 Nov 30;4(11):e900
pubmed: 21152057
Public Health Action. 2018 Dec 21;8(4):181-186
pubmed: 30775278
Sci Rep. 2020 Oct 1;10(1):16260
pubmed: 33004984
BMC Public Health. 2016 Dec 5;16(1):1225
pubmed: 27919240
BMJ Open. 2018 Mar 30;8(3):e020406
pubmed: 29602856
Trop Med Infect Dis. 2018 Mar 01;3(1):
pubmed: 30274425
N Engl J Med. 2019 Oct 3;381(14):1347-1357
pubmed: 31577876
J Clin Microbiol. 2018 Jun 25;56(7):
pubmed: 29720430
Am J Trop Med Hyg. 2014 Jun;90(6):1043-6
pubmed: 24710616
Am J Trop Med Hyg. 2019 May;100(5):1082-1084
pubmed: 30793685
Lancet. 2020 Feb 29;395(10225):709-733
pubmed: 32061315
J Hyg (Lond). 1913 Apr;13(1):1-34.1
pubmed: 20474526
Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1481-1485
pubmed: 30606321
Lancet Glob Health. 2019 Apr;7(4):e448-e460
pubmed: 30819531
J Med Microbiol. 2015 Aug;64(8):845-848
pubmed: 26055557
Influenza Other Respir Viruses. 2013 Sep;7(5):766-71
pubmed: 23122276
Trans R Soc Trop Med Hyg. 2018 Dec 01;112(12):568-570
pubmed: 30219869
BMC Infect Dis. 2016 Jun 10;16:265
pubmed: 27287260
Trop Med Infect Dis. 2019 Jan 04;4(1):
pubmed: 30621177
Am J Trop Med Hyg. 2007 Nov;77(5):812-3
pubmed: 17984331
PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2727
pubmed: 24651568
Lancet Infect Dis. 2019 Aug;19(8):892-902
pubmed: 31285144
Am J Trop Med Hyg. 2005 Dec;73(6):1165-6
pubmed: 16354832
Am J Trop Med Hyg. 2013 Nov;89(5):983-985
pubmed: 24062474
N Engl J Med. 2012 Sep 13;367(11):1035-44
pubmed: 22970946
Trans R Soc Trop Med Hyg. 2019 Dec 1;113(12):757-763
pubmed: 31638152
PLoS One. 2018 Mar 26;13(3):e0194595
pubmed: 29579128
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1169-1177
pubmed: 29594800
Diabetes Metab Syndr Obes. 2019 Mar 04;12:291-298
pubmed: 30881072
Trans R Soc Trop Med Hyg. 2019 Feb 1;113(2):56-64
pubmed: 30517697

Auteurs

Clare E Warrell (CE)

Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Medical Action Myanmar, Yangon, Myanmar.

Aung Pyae Phyo (AP)

Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.

Mo Mo Win (MM)

Department of Medical Research, Myanmar.

Alistair R D McLean (ARD)

Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Wanitda Watthanaworawit (W)

Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.

Myo Maung Maung Swe (MMM)

Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.

Kyaw Soe (K)

Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.

Htet Naing Lin (HN)

Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Medical Action Myanmar, Yangon, Myanmar.

Yee Yee Aung (YY)

Department of Medical Research, Myanmar.

Chitmin Ko Ko (CK)

Medical Action Myanmar, Yangon, Myanmar.

Cho Zin Waing (CZ)

Medical Action Myanmar, Yangon, Myanmar.

Kaung San Linn (KS)

Medical Action Myanmar, Yangon, Myanmar.

Yadanar Phoo Wai Aung (YPW)

Medical Action Myanmar, Yangon, Myanmar.

Ne Myo Aung (NM)

Department of Medicine, Insein General Hospital, Min Gyi Road, Insein Township, Yangon, Myanmar.
Department of Medicine, University of Medicine 2, Khaymar Thi Road, North Okkalapa Township, Yangon, Myanmar.

Ni Ni Tun (NN)

Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Medical Action Myanmar, Yangon, Myanmar.

David A B Dance (DAB)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic.
Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Frank M Smithuis (FM)

Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Medical Action Myanmar, Yangon, Myanmar.

Elizabeth A Ashley (EA)

Myanmar Oxford Clinical Research Unit, Yangon, Myanmar.
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic.
Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH